U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
- Avidity Biosciences, Inc. RNA shares jumped 44.3% to $15.84 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle.
- Wave Life Sciences Ltd. WVE surged 21.1% to $5.80. SVB Leerink maintained WAVE Life Sciences with a Market Perform and raised the price target from $2 to $7.
- Kymera Therapeutics, Inc. KYMR shares rose 21.4% to $31.38 after the company announced results from the Phase 1 clinical trial evaluating KT-474 in patients with HS and AD and Sanofi's decision to advance KT-474 into Phase 2 clinical trials.
- REV Group, Inc. REVG rose 17.2% to $15.57 as the company reported a fourth-quarter FY22 sales growth of 5.7% year-over-year to $623.6 million, beating the consensus of $595 million.
- Dyne Therapeutics, Inc. DYN gained 16.4% to $14.19.
- Harmonic Inc. HLIT gained 12.9% to $14.86
- Carvana Co. CVNA gained 12.8% to $5.45.
- Harrow Health, Inc. HROW surged 11.9% to $12.43. Harrow Health entered a binding agreement to acquire the exclusive U.S. commercial rights to five FDA‑approved ophthalmic products from Novartis.
- Bloom Energy Corporation BE gained 10.3% to $24.26. UBS initiated coverage on Bloom Energy with a Buy rating and announced a price target of $35.
- Mullen Automotive, Inc. MULN jumped 10% to $0.2354. Mullen Automotive partnered with Loop Global to deploy EV charging solutions, including public DC fast charging network and residential offerings.
- Oppenheimer Holdings Inc. OPY gained 9.7% to $44.19. Oppenheimer Holdings announced share repurchase program; authorizes the company to purchase up to 543,000 shares of the company's Class A non-voting common stock.
- SoFi Technologies, Inc. SOFI rose 9.7% to $4.86. SoFi Technologies CEO Anthony Noto reported purchase of 1,134,065 shares at ab average price of $4.42 per share.
- Mondee Holdings, Inc. MOND gained 8.8% to $9.50.
- Plug Power Inc. PLUG rose 8.3% to $15.29. UBS initiated coverage on Plug Power with a Buy rating and announced a price target of $26.
- Cytokinetics, Incorporated CYTK jumped 7.6% to $41.27. The FDA's Cardiovascular and Renal Drugs Advisory Committee voted 8-3 against the approval of Cytokinetics heart failure drug, omecamtiv mecarbil.
Check out this: Bitcoin Tops $18,000; GMX, Dogecoin Among Top Losers
Loading...
Loading...
BEBloom Energy Corp
$24.12-0.99%
Edge Rankings
Momentum
90.51
Growth
99.12
Quality
N/A
Value
12.42
Price Trend
Short
Medium
Long
CVNACarvana Co
$347.51-2.75%
CYTKCytokinetics Inc
$34.252.67%
DYNDyne Therapeutics Inc
$8.352.08%
HLITHarmonic Inc
$9.19-9.64%
HROWHarrow Inc
$31.25-0.35%
KYMRKymera Therapeutics Inc
$43.43-0.87%
MONDMondee Holdings Inc
$0.00100-%
MULNMullen Automotive Inc
$0.2109-12.1%
OPYOppenheimer Holdings Inc
$66.34-1.57%
PLUGPlug Power Inc
$1.412.92%
REVGREV Group Inc
$49.67-0.26%
RNAAvidity Biosciences Inc
$29.251.56%
SOFISoFi Technologies Inc
$20.044.15%
WVEWAVE Life Sciences Ltd
$6.95-1.56%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.